Pharmacology 2020 Event
ReadyCell actively interacts with the Drug Discovery community, introducing cell-based in vitro systems and easing novel compounds’ preclinical development.
Discover how in vitro Caco-2 cells help you evaluate novel therapeutic molecules
Caco-2 cells are considered a reference cellular model for basic research and drug discovery projects. ReadyCell supplies systems worldwide.
Readycell’s gratitude message
Due to the current situation and special circumstances, ReadyCell’s team would like to thank all healthcare professionals for the huge effort to contain the pandemic, which allows to carry on our daily lives.
PreadyTake MATE1, Screening Renal and Hepatic Drug Metabolism
In vitro systems based on HEK293 cells are a recommended technique to assess MATE1 transporter interactions during preclinical stages.
The latest FDA guidance on in vitro drug-drug interactions is finally out!
Among other things, the agency explains that DDIs are a critical factor in a drug’s overall benefit-risk profile.
